Ken Griffin Exscientia PLC Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$4.26 - $6.0 $2,982 - $4,200	-700 Reduced 58.33%	500 $2,000
Q2 2024 Aug 14, 2024	SELL	$3.99 - $6.04 $71,022 - $107,512	-17,800 Reduced 93.68%	1,200 $6,000
Q1 2024 May 15, 2024	SELL	$5.3 - $7.51 $22,790 - $32,293	-4,300 Reduced 18.45%	19,000 $108,000
Q4 2023 Feb 14, 2024	SELL	$4.35 - $6.88 $16,530 - $26,144	-3,800 Reduced 14.02%	23,300 $149,000
Q3 2023 Nov 14, 2023	BUY	$4.52 - $8.9 $70,060 - $137,950	15,500 Added 133.62%	27,100 $122,000
Q2 2023 Aug 14, 2023	SELL	$4.79 - $8.3 $12,933 - $22,410	-2,700 Reduced 18.88%	11,600 $68,000
Q1 2023 May 15, 2023	SELL	$5.3 - $10.93 $5,830 - $12,023	-1,100 Reduced 7.14%	14,300 $75,000
Q4 2022 Feb 14, 2023	SELL	$4.1 - $8.94 $16,810 - $36,654	-4,100 Reduced 21.03%	15,400 $82,000
Q3 2022 Nov 14, 2022	BUY	$7.27 - $12.92 $45,074 - $80,104	6,200 Added 46.62%	19,500 $160,000

100

33.5M

500

189K

Ticker EXAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 122,461,000
Market Cap $574M
Description
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.